This observational study reviewed thyroid eye disease patients treated with teprotumumab at one center, reporting common side effects like fatigue and dry eye symptoms, with serious adverse events including two cases of blood clots and one pulmonary embolism.
6 citations
,
September 2019 in “Indian Journal of Dermatology” February 2022 in “Veterinary record case reports” In this study, photobiomodulation therapy successfully treated hair cycle arrest in a Pembroke Welsh corgi with no adverse effects, suggesting a new potential treatment option for this condition.
150 citations
,
June 1999 in “Oncogene” May 2015 in “Cancer research” This study found that persistent significant alopecia was a common side effect following FEC-docetaxel chemotherapy, with a 33.4% global incidence, highlighting the need for awareness and potential preventative measures like cooling caps during treatment.
February 2024 in “Neurophotonics” This review highlights the potential of transcranial photobiomodulation (tPBM) as a non-invasive and affordable treatment for brain diseases, summarizing recent advances and successful protocols based on over two decades of research.
November 2007 in “The Journal of Urology” This editorial comments on long-term treatment options for benign prostatic hyperplasia but reports no new research findings.
2 citations
,
January 2023 in “Redox Report” This study found that estradiol significantly reduces cisplatin-induced cochlear hair cell death in mice, likely by activating Nrf2 and phase II detoxification enzymes.
2 citations
,
March 2022 in “Portuguese Journal of Nephrology & Hypertension” This manuscript describes two case reports of preterm newborns with a rare homozygous mutation in the epidermal growth factor receptor, leading to severe health issues and early mortality despite supportive care.
1 citations
,
September 2010 in “European Urology Supplements”
April 2019 in “Radiotherapy and oncology” HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.
May 2005 in “Seminars in Plastic Surgery” This article shares the authors' experiences with the erbium YAG laser in hair restoration surgery, noting improved graft yield and reduced thermal damage compared to traditional methods.
This overview of PRP Bristol clinics explains the growing popularity of Platelet-Rich Plasma therapy as a non-surgical treatment for early-stage hair loss, detailing its process, benefits, and suitability for individuals with androgenetic alopecia.
February 2019 in “Journal of Pakistan Association of Dermatologists” In this study, eflornithine cream combined with intense pulsed light treatment significantly improved facial hair removal in women with hirsutism compared to IPL treatment alone.
January 2024 in “Deleted Journal” This study reported that patients with radiation cystitis had significantly higher readmission rates compared to those with non-radiation cystitis, although their management and hospital stay durations were similar.
9 citations
,
January 2018 in “Plastic and Reconstructive Surgery – Global Open” Using PDRN injections and RF treatments improved revision nose surgery results without major side effects.
March 2026 in “Revista Ibero-Americana de Humanidades, Ciências e Educação” In this study, L-PRF was associated with successful osseointegration and tissue healing when used with biomaterial for dental implants in a patient with an atretic bone ridge.
125 citations
,
February 2007 in “Journal of the American Academy of Dermatology” This study found that adding topical eflornithine to laser hair removal significantly improved the reduction of unwanted facial hair in women over a 6-month period, compared to laser treatment alone.
May 2026 in “Journal of Cutaneous and Aesthetic Surgery” In this study, researchers developed a novel bio-enhanced hair transplant technique that, among 10 patients, provided aesthetically pleasing outcomes with minimal downtime, linear increases in density over nine months, and uneventful donor area healing with no visible scarring.
July 2026 in “Journal of Medical Imaging and Radiation Oncology” This study reviewed evidence on cutaneous reactions and associated radiation doses from cranial or spinal neurointerventional procedures, finding that alopecia/epilation was most common and onset doses often aligned with known thresholds, highlighting the need for standardized dose reporting and follow-up.
April 2026 in “Frontiers in Medicine” This study observed that 675-nm diode laser therapy may serve as a safe and possibly effective adjuvant treatment for telogen effluvium, showing improvements in hair pull test results, pruritus, and trichodynia among patients. However, controlled studies are needed to confirm its efficacy.
February 2026 in “European journal of medical research” This study found that combination therapy with alpha-adrenergic blockers and 5α-reductase inhibitors significantly improved urinary symptoms, reduced prostate volume, and decreased the risk of acute urinary retention and postoperative surgery in patients with benign prostatic hyperplasia compared to monotherapy.
39 citations
,
March 2009 in “Dermatology Online Journal” This review observes that trichomegaly, a newly described side effect of EGFR inhibitors causing excessive eyelash and scalp hair growth, persists in some patients whose tumors respond positively to the therapy.
November 2022 in “Journal of Cosmetic Dermatology” In this study, combining photobiomodulation therapy and pulsed electromagnetic field therapy over 24 weeks significantly increased hair density in androgenetic alopecia patients compared to a sham device control, with minimal side effects reported.
March 2024 in “Research Square (Research Square)” This study found no significant benefit of platelet-rich plasma injections over placebo in improving erectile function in patients with mild to moderate erectile dysfunction.
This chapter reviews procedural hair restoration techniques, including platelet-rich plasma and hair transplantation, and reports no new clinical findings.
147 citations
,
October 2021 in “Cancer Communications” This study found that the novel anti-HER2 antibody RC48 demonstrated promising activity and manageable safety in patients with HER2-overexpressing, advanced gastric or gastroesophageal junction cancer after at least two prior chemotherapy lines.
October 2022 in “Hair Transplantation” This article discusses the complexities of brow hair restoration and reports no new clinical results, emphasizing the meticulous and technically demanding nature of this procedure.
8 citations
,
March 2015 in “International Journal of Oncology” This study successfully established Tsc2-deficient embryonic stem cells from Eker rats and found these cells have distinct gene expression compared to non-mutant cells, which could help identify new therapeutic targets for TSC-related pathogenesis.
July 2021 in “British Journal of Dermatology” Laser treatment for skin conditions VEN and ILVEN is effective and liked by patients.